Literature DB >> 35533694

Case Report: Disseminated Strongloides stercoralis Presenting as an Ulcerated Gastric Mass in an HIV-1-infected Patient.

Kassa Tameru1, Bekure Tsegaye1, Mohammed Shikur1, Wondwossen Ergete2, Geremew Tasew3, Adugna Abera3, Dawit Wolday4.   

Abstract

Disseminated Strongloides stercoralis is a common phenomenon among patients with immunosuppression. In this report, we present a case of disseminated Strongloides stercoralis presenting as a gastric mass in a 42-year-old male patient with a known history of HIV-1 infection and type 2 diabetes mellitus (T2DM). The patient presented with symptoms and signs suggestive of acute on chronic erosive gastritis, which included persistent vomiting. Endoscopic examination revealed a gastric mass with no signs of malignancy or dysplasia. There was noted to be chronic inflammation along with morphologic features consistent with the larvae and eggs of Strongloides nematodes in a biopsied gastric mass tissue and duodenum. The disease subsequently resulted in death despite the administration of ivermectin.

Entities:  

Year:  2022        PMID: 35533694      PMCID: PMC9209934          DOI: 10.4269/ajtmh.21-0791

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   3.707


  15 in total

1.  Disseminated strongyloidiasis: a retrospective study of clinical course and outcome.

Authors:  C S Lam; M K H Tong; K M Chan; Y P Siu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2006-01       Impact factor: 3.267

Review 2.  Disseminated Strongyloides stercoralis in human immunodeficiency virus-infected patients. Treatment failure and a review of the literature.

Authors:  K D Lessnau; S Can; W Talavera
Journal:  Chest       Date:  1993-07       Impact factor: 9.410

3.  Strongyloides stercoralis infection presenting as an unusual cause of massive upper gastrointestinal bleeding in an immunosuppressed patient: a case report.

Authors:  Hyasinta Jaka; Mheta Koy; John P Egan; John R Meda; Mariam Mirambo; Humphrey D Mazigo; Rodrick Kabangila; Y Lynn Wang; Andreas Mueller; Robert N Peck; Mabula D Mchembe; Phillipo L Chalya
Journal:  Trop Doct       Date:  2013-02-26       Impact factor: 0.731

Review 4.  Strongyloides stercoralis in the Immunocompromised Population.

Authors:  Paul B Keiser; Thomas B Nutman
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

5.  Hyperinfection with Strongyloides stercoralis.

Authors:  Raúl Romero-Cabello; Javier Villagroy Gómez; Mercedes Hernández González; Raúl Romero Feregrino
Journal:  BMJ Case Rep       Date:  2012-11-30

6.  The spectrum of GI strongyloidiasis: an endoscopic-pathologic study.

Authors:  Bryan F Thompson; Lucía C Fry; Christopher D Wells; Martín Olmos; David H Lee; Audrey J Lazenby; Klaus E Mönkemüller
Journal:  Gastrointest Endosc       Date:  2004-06       Impact factor: 9.427

Review 7.  Strongyloidiasis--an insight into its global prevalence and management.

Authors:  Santhosh Puthiyakunnon; Swapna Boddu; Yiji Li; Xiaohong Zhou; Chunmei Wang; Juan Li; Xiaoguang Chen
Journal:  PLoS Negl Trop Dis       Date:  2014-08-14

8.  Epidemiology of intestinal helminthiases in a rural community of Ethiopia: Is it time to expand control programs to include Strongyloides stercoralis and the entire community?

Authors:  Aranzazu Amor Aramendia; Melaku Anegagrie; Derjew Zewdie; Elena Dacal; Jose M Saugar; Zaida Herrador; Tadesse Hailu; Mulat Yimer; María V Periago; Esperanza Rodriguez; Agustín Benito
Journal:  PLoS Negl Trop Dis       Date:  2020-06-04

Review 9.  Severe strongyloidiasis: a systematic review of case reports.

Authors:  Dora Buonfrate; Ana Requena-Mendez; Andrea Angheben; Jose Muñoz; Federico Gobbi; Jef Van Den Ende; Zeno Bisoffi
Journal:  BMC Infect Dis       Date:  2013-02-08       Impact factor: 3.090

10.  Clinical Characteristics of Disseminated Strongyloidiasis, Japan, 1975-2017.

Authors:  Mitsuru Mukaigawara; Masashi Narita; Soichi Shiiki; Yoshihiro Takayama; Shunichi Takakura; Tomokazu Kishaba
Journal:  Emerg Infect Dis       Date:  2020-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.